Reporting Side Effects in Cancer Clinical Trials - Metastatic Breast Cancer Trial Talk

Research News

More attention is now being paid to what types of side effects are reported in cancer clinical trials and how data on these side effects are collected.

Researchers are also expanding the data they collect to include patient-reported outcomes.

The articles below describe studies that have explored ways to collect patient-reported outcomes, why words like “tolerable” and “manageable” may not reflect patients’ actual experiences, the need for studies to collect data on how long side effects last, and ways to streamline reporting of adverse events to the FDA to improve patient safety.

Last Modified on February 3, 2021



for past articles or specific information.